Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Healthtrust
Medtronic
QuintilesIMS
Julphar

Generated: July 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,239,113

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,239,113 protect, and when does it expire?

Patent 6,239,113 protects AZASITE and is included in one NDA.

This patent has thirty patent family members in sixteen countries.

Summary for Patent: 6,239,113
Title: Topical treatment or prevention of ocular infections
Abstract:The topical application of an azalide antibiotic such as azithromycin to the eye is useful in treating or preventing ocular infections. In one embodiment, the azalide antibiotic is supplied to the eye in a depot for sustained release. A more convenient dosing regimen can also be provided by the use of an appropriate depot. Furthermore, a composition containing a combination of medicaments is also provided.
Inventor(s): Dawson; Chandler R. (Mill Valley, CA), Bowman; Lyle M. (Pleasanton, CA)
Assignee: InSite Vision, Incorporated (Alameda, CA)
Application Number:09/346,923
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,239,113
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,239,113
Patent Claim Types:
see list of patent claims
Use; Process;

Drugs Protected by US Patent 6,239,113

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Oak Pharms Inc AZASITE azithromycin SOLUTION/DROPS;OPHTHALMIC 050810-001 Apr 27, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF COMBATING BACTERIA IN A PATIENT ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,239,113

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 296093 ➤ Try a Free Trial
Australia 2002322002 ➤ Try a Free Trial
Australia 3920300 ➤ Try a Free Trial
Australia 772228 ➤ Try a Free Trial
Canada 2368637 ➤ Try a Free Trial
Canada 2445408 ➤ Try a Free Trial
Cyprus 1107259 ➤ Try a Free Trial
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Mallinckrodt
Fish and Richardson
Citi
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.